Cargando…

Individualized Glycemic Control in Type 2 Diabetic Patients in Iran: A Multi-Center Data Analysis

BACKGROUND: Clinical guidelines and expert committees have recently suggested that the hemoglobin A1C (HbA1c) should be individualized based on various criteria. Data regarding the achievement of individualized glycemic targets in type 2 diabetes mellitus (T2DM) patients is scant in Iran. We intende...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sadeghi, Abolfazl, Bayazidi, Yahya, Davari, Majid, Kebriaeezadeh, Abbas, Assarian, Amin, Esteghamati, Alireza, Yousefi, Sepideh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Shiraz University of Medical Sciences 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542933/ https://www.ncbi.nlm.nih.gov/pubmed/37791332 http://dx.doi.org/10.30476/ijms.2022.92805.2409

Ejemplares similares

Quality of care in type 2 diabetes in Iran; a cross-sectional study using patient-level data
por: Davari, Majid, et al.
Publicado: (2022)

Long-term cost-effectiveness of quality of diabetes care; experiences from private and public diabetes centers in Iran
por: Shahtaheri, Rahill Sadat, et al.
Publicado: (2022)

Evaluation of Urban and Rural Family Physician Program in Iran: A Systematic Review
por: KHEDMATI, Jamaleddin, et al.
Publicado: (2019)

Is Albumin-based Resuscitation in Severe Sepsis and Septic Shock Justifiable? An Evidence from a Cost-effectiveness Evaluation
por: Tigabu, Bereket, et al.
Publicado: (2019)

Cost-effectiveness of hypertension therapy based on 2020 International Society of Hypertension guidelines in Ethiopia from a societal perspective
por: Davari, Majid, et al.
Publicado: (2022)

The Direct Medical Costs of Outpatient Cares of Type 2 Diabetes in Iran: A Retrospective Study
por: Davari, Majid, et al.
Publicado: (2016)

Societal economic burden of hypertension at selected hospitals in southern Ethiopia: a patient-level analysis
por: Sorato, Mende Mensa, et al.
Publicado: (2022)

The Clinical Efficacy of Imiglucerase versus Eliglustat in Patients with Gaucher's Disease Type 1: A Systematic Review
por: Nabizadeh, Azita, et al.
Publicado: (2018)

Biphasic insulin Aspart 30 vs. NPH plus regular human insulin in type 2 diabetes patients; a cost-effectiveness study
por: Farshchi, Amir, et al.
Publicado: (2016)

Evaluation of Factors Affecting Prescribing Behaviors, in Iran Pharmaceutical Market by Econometric Methods
por: Tahmasebi, Nima, et al.
Publicado: (2015)

Cost-effectiveness of a population-based AAA screening program for men over 65 years old in Iran
por: Daroudi, Rajabali, et al.
Publicado: (2021)

Reasons for poor blood pressure control in Eastern Sub-Saharan Africa: looking into 4P’s (primary care, professional, patient, and public health policy) for improving blood pressure control: a scoping review
por: Sorato, Mende Mensa, et al.
Publicado: (2021)

Health status and quality of life in patients with severe hemophilia A: A cross-sectional survey
por: Davari, Majid, et al.
Publicado: (2019)

Prevalence of Substance Abuse among Students of Tehran University of Medical Sciences, Iran
por: Mozafarinia, Rosanna, et al.
Publicado: (2017)

The cost of diabetes chronic complications among Iranian people with type 2 diabetes mellitus
por: Farshchi, Amir, et al.
Publicado: (2014)

Trend Analysis of Medicine Consumption Based on Therapeutic Categories in Iran: 2000–2016
por: Yektadoost, Alireza, et al.
Publicado: (2018)

Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran
por: Aajami, Zahra, et al.
Publicado: (2019)

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
por: Rezvanfar, Mohammad Ali, et al.
Publicado: (2013)

Diabetes-related distress and its association with the complications of diabetes in Iran
por: Khashayar, Pouria, et al.
Publicado: (2022)

The Impact of the Sanctions Made Against Iran on Availability to Asthma Medicines in Tehran
por: Ghiasi, Golbarg, et al.
Publicado: (2016)

Assessment of Influential Variables in the Pricing of Locally Manufactured Pharmaceuticals: Current Challenging Situation in Iran
por: Ashrafi Shahmirzadi, Nikinaz, et al.
Publicado: (2021)

Pharmacoeconomics; an Appropriate Tool for Policy Makers or Just a New Field of Research in Iran?
por: Davari, Majid
Publicado: (2012)

The Direct Medical Costs of Breast Cancer in Iran: Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan
por: Davari, Majid, et al.
Publicado: (2013)

Pharmaceutical subsidy policy in Iran: a qualitative stakeholder analysis
por: Olyaaeemanesh, Alireza, et al.
Publicado: (2021)

Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods
por: Jaberidoost, Mona, et al.
Publicado: (2015)

Clinical Lipid Control Success Rate Before and After Percutaneous Coronary Intervention in Iran; a Single Center Study
por: Hosseini, Seyed Kianoosh, et al.
Publicado: (2013)

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

Fecal calprotectin Level in patients with IBD and noninflammatory disease of colon: a study in Babol, Northern, Iran
por: Sharbatdaran, Majid, et al.
Publicado: (2018)

Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study
por: Delpasand, Mansoor, et al.
Publicado: (2021)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
por: Nikfar, Shekoufeh, et al.
Publicado: (2005)

The Direct Medical Costs of Colorectal Cancer in Iran; Analyzing the Patient's Level Data from a Cancer Specific Hospital in Isfahan
por: Davari, Majid, et al.
Publicado: (2012)

Correction to: Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study
por: Delpasand, Mansoor, et al.
Publicado: (2021)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

Psychiatry in Iran
por: Sadeghi, Majid, et al.
Publicado: (2005)

Commercialization of biopharmaceutical knowledge in Iran; challenges and solutions
por: Nassiri-Koopaei, Nasser, et al.
Publicado: (2014)

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
por: Keshavarz, Khosro, et al.
Publicado: (2012)

Pharmaceutical laws and regulations in Iran: An overview
por: Zaboli, Pardis, et al.
Publicado: (2016)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012)

Behavioral Change Challenges in the Context of Center-Based Cardiac Rehabilitation: A Qualitative Study
por: Jokar, Fariba, et al.
Publicado: (2015)

Measles Elimination Successful and Its Relevant Challenges in Iran
por: Hosseinalipour, Seyed Abbas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_56kf977m5dfhr4e1r81tki46sb